Trial intelligence / Profile preview

Single-Dose Intravenous Inositol in Preterm Infants

NCT00349726Phase 2Completed

Sponsor
NICHD Neonatal Research Network
Start
Jun 2006
Primary completion
Dec 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of myo-inositol in retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), sponsored by NICHD Neonatal Research Network. Started Jun 2006; status: completed.

02

Drugs

myo-inositol
03

Conditions

retinopathy of prematurity (ROP)bronchopulmonary dysplasia (BPD)

Beyond the preview

Go deeper on NCT00349726.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00349726.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call